Iain T. Cameron — Endo Lab

review 2017

British medical bulletin ·doi:10.1093/bmb/ldx027

Introduction: It is not uncommon for a woman to suffer from abnormal uterine bleeding (AUB) or heavy menstrual bleeding (HMB) at some point during her lifetime. Once pathology is excluded, in practice, management needs to be individualised,…

review 2003

Menorrhagia in the menopause

·doi:10.1258/136218003100322017

review 2003

The Mirena(R) levonorgestrel system

Drugs of today (Barcelona, Spain : 1998) ·doi:10.1358/dot.2003.39.12.799415

The levonorgestrel intrauterine system is a safe, efficacious, long-term contraceptive device. Additionally, it results in a decrease in the volume of menstrual blood loss in women with normal periods and those with menorrhagia. It may also…

review 1999

Medical management of dysfunctional uterine bleeding

·doi:10.1053/beog.1999.0017

Complaints of excessive menstrual bleeding (menorrhagia) have a substantial impact on gynaecological services and in most cases no organic pathology is identified. Up to 50% of women who present with menorrhagia have blood losses within the…

review 1989

6 Dysfunctional uterine bleeding

·doi:10.1016/s0950-3552(89)80024-0

The diagnosis of DUB is made by the exclusion of organic disease as a cause of the abnormal menses; the condition accounts for about 80% of cases of menorrhagia. Of these, over 80% will have no abnormality of the hypothalamo-pituitary-ovari…

article 1987

The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia

·doi:10.1016/0090-6980(87)90267-x

The effects of four medical treatments have been assessed on menstrual blood loss (MBL) and endometrial prostaglandin (PG) concentrations in 30 women with objectively confirmed menorrhagia. Patients were randomly treated with danazol, 200 m…